celecoxib has been researched along with citalopram in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Karch, AM; Karch, FE | 1 |
| Edberg, D; Fareed, J; Halaris, A; Hoppensteadt, D; Sinacore, J; Walborn, A | 1 |
| Cantos, A; Hakimi, M; Halaris, A; Johnson, K; Sinacore, J | 1 |
| Fareed, J; Halaris, A; Hoppensteadt, D; Murata, S; Murphy, M; Welborn, A | 1 |
| Castillo, MFR; Cohen, A; Edberg, D; Fareed, J; Halaris, A; Hoppensteadt, D; Martin, B | 1 |
| Anthony, DC; Cespuglio, R; Lesch, KP; Lyundup, A; Pavlov, D; Proshin, A; Strekalova, T; Svistunov, A; Trofimov, A; Umriukhin, A | 1 |
1 review(s) available for celecoxib and citalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for celecoxib and citalopram
| Article | Year |
|---|---|
Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Body Mass Index; C-Reactive Protein; Celecoxib; Citalopram; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Statistics, Nonparametric; Time Factors; Young Adult | 2018 |
Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Bipolar Disorder; Celecoxib; Citalopram; Cyclooxygenase 2 Inhibitors; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome | 2020 |
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depression.
Topics: Bipolar Disorder; Celecoxib; Citalopram; Depressive Disorder, Treatment-Resistant; Humans; Interleukin-1beta; Kynurenine | 2020 |
Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Celecoxib; Citalopram; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult | 2020 |
6 other study(ies) available for celecoxib and citalopram
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
What did you say? I can't quite understand your spoken order.
Topics: Antidepressive Agents, Second-Generation; Arthritis; Celecoxib; Citalopram; Cyclooxygenase Inhibitors; Drug Prescriptions; Female; Humans; Medication Errors; Middle Aged; Nursing Staff, Hospital; Pain; Pyrazoles; Speech Intelligibility; Sulfonamides; Terminology as Topic; United States | 1999 |
Hippocampal Over-Expression of Cyclooxygenase-2 (COX-2) Is Associated with Susceptibility to Stress-Induced Anhedonia in Mice.
Topics: Anhedonia; Animals; Antidepressive Agents; Celecoxib; Citalopram; Cyclooxygenase 2; Depression; Hindlimb Suspension; Hippocampus; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming | 2022 |